360 results on '"Puech, A. J."'
Search Results
2. Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats
3. Initial monoamine oxidase-A inhibition by moclobemide does not predict the therapeutic response in patients with major depression A double blind, randomized study: A double blind, randomized study
4. Failure of CCK receptor ligands to modify anxiety-related behavioural suppression in an operant conflict paradigm in rats
5. A randomized double-blind placebo-controlled study of tropisetron in the treatment of outpatients with generalized anxiety disorder
6. Beta-adrenoceptor blockade potentiates acute exercise-induced release of atrial natriuretic peptide by increasing atrial diameter in normotensive healthy subjects
7. Potentiation by low doses of selected neuroleptics of food-induced conditioned place preference in rats
8. Safety signal withdrawal: a behavioural paradigm sensitive to both “anxiolytic” and “anxiogenic” drugs under identical experimental conditions
9. Reversal of helpless behavior by serotonin uptake blockers in rats
10. Evaluation and comparison of the interaction between alcohol and moclobemide or clomipramine in healthy subjects
11. Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects
12. Benefits from mianserin augmentation of fluoxetine in patients with major depression non-responders to fluoxetine alone
13. Blunted 5-HT1A-receptor agonist-induced corticotropin and cortisol responses after long-term ipsapirone and fluoxetine administration to healthy subjects
14. Effects of Befloxatone, a Reversible Selective Monoamine Oxidase-A Inhibitor, on Psychomotor Function and Memory in Healthy Subjects
15. Comparative investigation of the effect of moclobemide and toloxatone on monoamine oxidase activity and psychometric performance in healthy subjects
16. Treatment of Negative Symptoms in Schizophrenia with Amisulpride
17. DIAZEPAM AND BUSPIRONE DIFFERENTIALLY INTERFER WITH “ANXIOGENIC” DRUGS IN A SAFETY SIGNAL WITHDRAWAL PARADIGM OF CONFLICT BEHAVIOUR IN RATS
18. Practical aspects of the utilization of double-blind trials using adjusted doses of psychotropic drugs
19. Evaluation of Clinical and Biological Parameters in Healthy Volunteers: More than Pharmacokinetics and Side Effects?
20. Is it dexfenfluramine or weight loss that reduces blood pressure and noradrenergic activity in obese patients?
21. Troleandomycin-triazolam interaction in healthy volunteers: Pharmacokinetic and psychometric evaluation
22. Effects de quatre bloqueurs bêta-adrénergiques sur quelques tests de psychopharmacologie chez la Souris
23. Antagonism of hypothermia and behavioral response to apomorphine: A simple, rapid and discriminating test for screening antidepressants and neuroleptics
24. Evidence for the role of noradrenaline in some effects of quipazine
25. ARE METHYLERGOMETRINE AND 2-Br-ALPHA-METHYLERG0C0RNINE (CB 154) TYPICAL CENTRAL DOPAMINERGIC STIMULANT DRUGS?
26. PROBLEMS OF PHARMACOLOGICAL SCREENING FOR ANTIDEPRESSANTS
27. Problems of Pharmacological Screening for Antidepressants
28. REVERSAL OF DECREASE IN LOCOMOTOR ACTIVITY AND OEDEMA INDUCED BY YEAST IN MICE
29. Treatment of Positive and Negative Symptoms: Pharmacologic Approaches
30. Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects
31. Dopaminergic drug response and the genotype (Taq IA polymorphism) of the dopamine D2 receptor
32. Serum thyroid-stimulating-hormone concentration as an index of severity of major depression
33. El polimorfismo Taql A del gen del receptor D2 de la dopamina no se asocia con la búsqueda de novedad, la evitación del daño y la dependencia de la recompensa en los sujetos sanos
34. Medidas de anhedonia y respuestas hedónicas a la sacarosa en pacientes depresivos y esquizofrénicos en comparación con sujetos sanos
35. Involvement of central cannabinoid (CB 1 ) receptors in the establishment of place conditioning in rats
36. Whole blood serotonin content, tryptophan concentrations, and impulsivity in anorexia nervosa
37. Influence of anxiolytic drugs on the effects of specific serotonin reuptake inhibitors in the forced swimming test in mice
38. Antagonism by benzodiazepines of the effects of serotonin-, but not norepinephrine-, uptake blockers in the learned helplessness paradigm in rats
39. Monoamine oxidase A and B activities in heavy smokers
40. A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers*
41. Beta-adrenoceptor agonists do not stimulate daytime melatonin secretion in healthy subjects a double blind placebo controlled study
42. Suspected postprandial hypoglycemia is associated with beta-adrenergic hypersensitivity and emotional distress.
43. Effects of 5-HT1A receptor ligands on a safety signal withdrawal procedure of conflict in the rat
44. Reduction of hyperglycemia after oral glucose load by the new α2-adrenergic receptor antagonist SL 84.0418 in healthy subjects
45. Comparison of the Effects of Zolpidem and Triazolam on Memory Functions, Psychomotor Performances, and Postural Sway in Healthy Subjects
46. How to improve the risk-benefit ratio of antidepressants
47. Comparative study of the psychomotor and antistress effects of ritanserin, alprazolam and diazepam in healthy subjects: some trait anxiety-independent responses
48. Animal Behavioural Studies in the Evaluation of Antidepressant Drugs
49. 5-HT3 receptor antagonists reverse helpless behaviour in rats
50. INTERACTION OF DIAZEPAM AND BUSPIRONE WITH “ANXIOGENIC” COMPOUNDS IN A SAFETY SIGNAL WITHDRAWAL PARADIGM OF CONFLICT BEHAVIOUR IN RATS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.